You searched for "RPE"
Microdroplet and splatter contamination during phacoemulsification in COVID-19 era
3 June 2021
| Ivan Yip
|
EYE - Cataract, EYE - Refractive
|
COVID-19, SARS-CoV-2, aerosol-generating procedure, microdroplet generating procedure, phacoemulsification cataract surgery
Half a millilitre of fluorescein was incorporated into 400ml of balanced salt solution to identify microdroplet and splatter from phacoemulsification to simulate possible COVID-19 contamination. Five porcine eyes were mounted to an ophthalmic mannequin head and two surgeons (height 189cm,...
Optical practices to continue to provide urgent and essential care
25 March 2020
The UK Government has now published further guidance clarifying that opticians are exempt from the general requirement for retail businesses and premises to close.
Optical practices may therefore continue to provide urgent and essential eye care to the extent that they can, including remote care, while managing COVID-19 risk to keep patients, staff and the public as safe as possible.
Ophthalmology in the COVID-19 pandemic
The novel coronavirus pandemic has affected the whole world and forced all of us to think of new ways to manage our day to day personal as well as professional life. I am not going to talk about the clinical...Optimising an acute eye service in the current COVID-19 crisis
5 June 2020
| Patrick Hughes, Julia Sieberer, Inderpaul S Sian
|
EYE - General
With the current global pandemic of COVID-19 we have all had to redesign and reorganise our normal working practices. Non-urgent hospital work has been postponed to allow redistribution of resources, redeployment of hospital staff and to reduce the risk of...
Resurfacing the ocular surface
1 April 2016
| Harminder Dua (Prof)
|
EYE - Cornea
The ocular surface (OS) is an anatomical and functional unit made of the tear film, the conjunctival, limbal and corneal epithelium, the lacrimal, mucous and meibomian glands and the lids and blink reflex. The tear film is composed of a...
Is patient masking leading to an increase in post-op infection after eyelid surgery?
21 October 2020
| Marion Sikuade, Jennifer HY Tan, Zanna Currie
|
EYE - Oculoplastic
Due to the COVID-19 pandemic, the use of facemasks or face coverings in the clinical setting has become necessary. It is important to recognise that facemasks can be a source of infection after eye surgery and consider ways to minimise...
Providing primary eyecare services during a global pandemic: the new normal
7 December 2020
| Janet Pooley
|
EYE - General
It would be fair to say that 2020 hasn’t quite turned out to be the year that anyone predicted. Living with a global pandemic has become our reality and we are having to get used to many aspects of our...
Novel changes during COVID-19 – transforming a walk-in Eye Casualty to a telephone triage service
18 February 2021
| Karishma Parmar, Riddhi Thaker, Deepa Rathore
|
EYE - General
With the current pandemic climate due to COVID-19, out of the norm approaches have been adopted in different hospitals across the UK to ensure patient safety. At our Eye Casualty (EC) department at Northampton General Hospital (NGH), we felt the...
Radiation retinopathy
The authors review the current treatment options for this condition. Radiation retinopathy (RR) occurs as a complication after exposure to any type of radiation (external beam, plaque brachytherapy and stereotactic radiosurgery) in the orbital or adnexal region. These include nasopharyngeal...The role of inflammation in the pathophysiology of DMO
1 February 2016
| Fiona Harris, Spyridon Chalkiadakis, Simon Taylor (Prof)
|
EYE - Vitreo-Retinal
Diabetic macular oedema (DMO) is a major cause of visual loss in diabetes, with a complex multifactorial pathogenesis. In the UK alone it is estimated that there are nearly 2.5 million diabetic patients aged over 12 years. Approximately 65,000 of...
Neovascular AMD: fresh recommendations underline standards of best practice
1 December 2013
| Rod McNeil
The management of neovascular age-related macular degeneration (nAMD) has advanced dramatically over the past seven years, with the introduction of targeted new therapies that successfully maintain or improve vision in a majority of affected individuals. It’s a fast moving field,...
